Meeder Asset Management Inc Opti Nose, Inc. Transaction History

Meeder Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$3.58 - $7.44 $2,205 - $4,583	-616 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.49 - $9.2 $2,149 - $5,667	616 New	616 $3,000
Q1 2018 May 03, 2018	SELL	$15.91 - $20.82 $731 - $957	-46 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$15.2 - $20.76 $699 - $954	46	46 $1,000

5.29M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $481M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.